399 related articles for article (PubMed ID: 16048833)
61. The rise of new psychoactive substance use in Australia.
Burns L; Roxburgh A; Matthews A; Bruno R; Lenton S; Van Buskirk J
Drug Test Anal; 2014; 6(7-8):846-9. PubMed ID: 24599890
[TBL] [Abstract][Full Text] [Related]
62. An evaluation of a brief motivational intervention among young ecstasy and cocaine users: no effect on substance and alcohol use outcomes.
Marsden J; Stillwell G; Barlow H; Boys A; Taylor C; Hunt N; Farrell M
Addiction; 2006 Jul; 101(7):1014-26. PubMed ID: 16771893
[TBL] [Abstract][Full Text] [Related]
63. The effects of stereotype threat on cognitive function in ecstasy users.
Cole JC; Michailidou K; Jerome L; Sumnall HR
J Psychopharmacol; 2006 Jul; 20(4):518-25. PubMed ID: 16174670
[TBL] [Abstract][Full Text] [Related]
64. Possible association between 3,4-methylenedioxymethamphetamine abuse and valvular heart disease.
Droogmans S; Cosyns B; D'haenen H; Creeten E; Weytjens C; Franken PR; Scott B; Schoors D; Kemdem A; Close L; Vandenbossche JL; Bechet S; Van Camp G
Am J Cardiol; 2007 Nov; 100(9):1442-5. PubMed ID: 17950805
[TBL] [Abstract][Full Text] [Related]
65. Getting into ecstasy: comparing moderate and heavy young adult users.
Sterk CE; Theall KP; Elifson KW
J Psychoactive Drugs; 2007 Jun; 39(2):103-13. PubMed ID: 17703705
[TBL] [Abstract][Full Text] [Related]
66. Can the severity of dependence scale be usefully applied to 'ecstasy'?
Bruno R; Matthews AJ; Topp L; Degenhardt L; Gomez R; Dunn M
Neuropsychobiology; 2009; 60(3-4):137-47. PubMed ID: 19893331
[TBL] [Abstract][Full Text] [Related]
67. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
Parrott AC
J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
[TBL] [Abstract][Full Text] [Related]
68. Polysubstance use and its correlates in adolescent ecstasy users in Taiwan.
Yen CF; Hsu SY; Cheng CP
Addict Behav; 2007 Oct; 32(10):2286-91. PubMed ID: 17314013
[TBL] [Abstract][Full Text] [Related]
69. A case of drug-facilitated sexual assault involving 3,4-methylenedioxy-methylamphetamine.
Eiden C; Cathala P; Fabresse N; Galea Y; Mathieu-Daudé JC; Baccino E; Peyrière H
J Psychoactive Drugs; 2013; 45(1):94-7. PubMed ID: 23662335
[TBL] [Abstract][Full Text] [Related]
70. Lhermitte's sign, electric shock sensations and high dose ecstasy consumption: preliminary findings.
Boland B; Mitcheson L; Wolff K
J Psychopharmacol; 2010 Feb; 24(2):213-20. PubMed ID: 19240087
[TBL] [Abstract][Full Text] [Related]
71. Information processing speed in ecstasy (MDMA) users.
Wareing M; Fisk JE; Montgomery C; Murphy PN; Chandler MD
Hum Psychopharmacol; 2007 Mar; 22(2):81-8. PubMed ID: 17295197
[TBL] [Abstract][Full Text] [Related]
72. [Ecstasy is a dangerous drug the society chooses to ignore].
Heilig M
Lakartidningen; 2003 Feb; 100(9):688-90. PubMed ID: 12674555
[No Abstract] [Full Text] [Related]
73. Rapidly progressive parkinsonism in a self-reported user of ecstasy and other drugs.
O'Suilleabhain P; Giller C
Mov Disord; 2003 Nov; 18(11):1378-81. PubMed ID: 14639685
[TBL] [Abstract][Full Text] [Related]
74. The neuropsychology of ecstasy (MDMA) use: a quantitative review.
Zakzanis KK; Campbell Z; Jovanovski D
Hum Psychopharmacol; 2007 Oct; 22(7):427-35. PubMed ID: 17896346
[TBL] [Abstract][Full Text] [Related]
75. Outcome expectancies and ecstasy use in visitors of rave parties in The Netherlands.
Engels RC; ter Bogt T
Eur Addict Res; 2004; 10(4):156-62. PubMed ID: 15367816
[TBL] [Abstract][Full Text] [Related]
76. Ecstasy and the concomitant use of pharmaceuticals.
Copeland J; Dillon P; Gascoigne M
Addict Behav; 2006 Feb; 31(2):367-70. PubMed ID: 15961251
[TBL] [Abstract][Full Text] [Related]
77. Depressive symptomatology in young adults with a history of MDMA use: a longitudinal analysis.
Falck RS; Wang J; Carlson RG
J Psychopharmacol; 2008 Jan; 22(1):47-54. PubMed ID: 18187532
[TBL] [Abstract][Full Text] [Related]
78. Ecstasy related periodontitis and mucosal ulceration -- a case report.
Brazier WJ; Dhariwal DK; Patton DW; Bishop K
Br Dent J; 2003 Feb; 194(4):197-9. PubMed ID: 12627194
[TBL] [Abstract][Full Text] [Related]
79. Is the use of ecstasy and hallucinogens increasing? Results from a community study.
Schuster P; Lieb R; Lamertz C; Wittchen HU
Eur Addict Res; 1998 Mar; 4(1-2):75-82. PubMed ID: 9740820
[TBL] [Abstract][Full Text] [Related]
80. Transient haemolytic anaemia due to ecstasy in a patient on HAART.
Goorney BP; Scholes P
Int J STD AIDS; 2002 Sep; 13(9):651. PubMed ID: 12243137
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
